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Lipins are the foundingmembers of a novel family of Mg2-de-
pendent phosphatidate phosphatases (PAP1 enzymes) that play
key roles in fat metabolism and lipid biosynthesis. Despite their
importance, there is still little information on how their activity is
regulated. Here we demonstrate that the functions of lipin 1 and 2
are evolutionarily conserved from unicellular eukaryotes to mam-
mals. The two lipins display distinct intracellular localization in
HeLa M cells, with a pool of lipin 2 exhibiting a tight membrane
association. Small interfering RNA-mediated silencing of lipin 1
leads toadramaticdecreaseof thecellularPAP1activity inHeLaM
cells,whereassilencingof lipin2 leads toan increaseof lipin1 levels
andPAP1activity.Consistentwith their distinct functions inHeLa
M cells, lipin 1 and 2 exhibit reciprocal patterns of protein expres-
sion in differentiating 3T3-L1 adipocytes. Lipin 2 levels increase in
lipin 1-depleted 3T3-L1 cells without rescuing the adipogenic
defects, whereas depletion of lipin 2 does not inhibit adipogenesis.
Finally,we showthat thePAP1activityofboth lipins is inhibitedby
phosphorylation duringmitosis, leading to a decrease in the cellu-
larPAP1activity during cell division.Wepropose that distinct and
non-redundant functions of lipin 1 and2 regulate lipid production
during the cell cycle and adipocyte differentiation.
The phospholipid composition of biological membranes is
crucial for many aspects of cell physiology, including growth,
differentiation, and transport (1, 2). Phospholipids are also
active participants of signaling cascades that control diverse
cellular functions (3). Two key precursors of phospholipid bio-
synthesis are PA3 and DAG, both of which have essential func-
tions in signaling cascades, energy storage, and lipid biosyn-
thetic pathways. Early biochemical studies identified a soluble
Mg2-dependent PA phosphatase (PAP1) activity that is key to
catalyzing PA conversion to DAG (4–6). DAG has multiple
functions. First, DAG is used for the synthesis of themost abun-
dant phospholipids found in biological membranes, phosphati-
dylcholine, and phosphatidylethanolamine (6). Second, DAG is
also used for the synthesis of the neutral lipid triacylglycerol, an
essential storage form of energy and fatty acids, which accumu-
lates as lipid droplets in adipocytes (7, 8). Despite the key role of
the PAP1 reaction, the identity of the enzyme(s) responsible for
this activity remained unknown until recently. Han et al. (9)
have demonstrated that Pah1p/Smp2p is the PAP1 enzyme
controlling biosynthetic production of phospholipids and tria-
cylglycerol in yeast. A separate study found that Pah1p regu-
lates transcription ofmany phospholipid biosynthetic enzymes,
nuclear/ER membrane biogenesis, and nuclear structure (10).
Mammals express three Pah1p-related proteins called lipins 1,
2, and 3 (11). Two closely related lipin 1 isoforms have been
described, the formandthe form,whichcontainsa short inser-
tion close to its N-terminal end (12). All members of the Pah1p/
lipin familyexhibit the sameprimaryorganization; theyare soluble
proteins containing a very conservedN-terminal domain of100
amino acid residues of unknown function and a C-terminal halo-
acid dehalogenase-like domain that contains the catalytic site.
Recent studies have demonstrated thatmammalian lipins possess
PAP1 activity (9, 13, 14). Lipin 1 was originally identified through
positional cloning as themutated gene in the fatty liver dystrophy
(fld) mouse (11). These mice are characterized by significantly
reduced adipose tissue mass throughout the body, insulin resist-
ance, and a progressive peripheral neuropathy (11). Consistent
with itsmetabolic functions inadipogenesis,high levelsof lipin1 in
transgenic mice promotes obesity (15). Recent studies have also
implicated lipin 1 in the regulation of gene expression of hepatic
lipid metabolic enzymes (16).
Despite this progress, there is still relatively little information
about the function of lipin 1 in cell physiology, especially out-
side adipocytes, and essentially no functional information
about lipins 2 and 3. If lipins, like Pah1p, are responsible for the
production of biosynthetic pools of phospholipids, then tempo-
ral and spatial regulation of their activity would be expected to
play an important role in membrane biogenesis. Interestingly,
the three lipins exhibit distinct but overlapping expression pat-
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terns inmany tissues (14), raising the question of the functional
differences of the various paralogues expressedwithin the same
cell. We report here that the function of lipins is evolutionarily
conserved from unicellular eukaryotes to mammals. We pro-
vide the first evidence that lipin 1 and 2 exhibit distinct intra-
cellular localization in HeLaM cells and show that lipin 1 is the
major PAP1 enzyme in HeLa M cells. siRNA-mediated deple-
tion of the two lipins shows that their expression is reciprocally
regulated both in HeLa M cells and differentiating adipocytes.
Finally, we demonstrate that the activity and solubility of both
lipins is regulated in a cell cycle-dependent manner by mitotic
phosphorylation.
EXPERIMENTAL PROCEDURES
Reagents, Plasmids, and Yeast Methods—Unless otherwise
stated, all of the reagents were supplied by Sigma-Aldrich.
MGC clones (Invitrogen) containing the full-length cDNA for
human lipin 1 (3906281) and mouse lipin 2 (5101211) were
subcloned into high copy (YEplac181-LEU2) yeast expression
vectors. The original lipin 2 clone contained a nonconserved 5
115-nucleotide sequence thatwas removed fromall subsequent
constructs. Single HA tag or GFP tags were added to the C
termini of lipin 1 and 2 using standard PCR cloning techniques,
and expression in HeLa M cells was driven by cytomegalovirus
promoter-based vectors. PAH1-, lipin 1-, and lipin 2-GFP
C-terminal fusions were cloned into a high copy vector
(YEplac181) and expressed in the pah1 strain (10). Transfor-
mations, protein extracts, and microscopy of yeast cells were
performed as previously described (10).
Lipin 1 and Lipin 2 Antibody Production—The nucleotide
sequences of human lipin1 (corresponding to amino acid resi-
dues 190–526) and mouse lipin2 (331–548) were cloned into
pGEX4T1, and glutathione S-transferase-tagged fusion pro-
teinswere purified frombacterial lysate supernatants using glu-
tathione-Sepharose 4B (Amersham Biosciences). Antibodies
against the glutathione S-transferase fusion proteins (500g of
protein/injection) were raised in rabbits by three subcutaneous
injections over 66 days. Affinity purification of the antibodywas
carried out by coupling the glutathione S-transferase fusion
proteins to CNBr-activated Sepharose (Amersham Bio-
sciences) following the product specifications. Rabbit sera from
the final bleeds were then incubated with the CNBr-activated
Sepharose fusion protein complex for 2 h at 4 °C beforewashing
with PBS. Subsequent elution of the bound antibodies was car-
ried out using 200 mM glycine-HCl (pH 2.3), which was then
neutralized immediately with 1 M Tris-HCl (pH 7.4).
Cell Culture, Transfections, and siRNA Knockdowns—HeLa
M cells were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum and 2 mM
L-glutamine in a humidified 37 °C incubator with 5% CO2.
Transfections of HeLa M cells with plasmids and siRNA oligo-
nucleotides were carried out using the standard protocols sup-
plied with TransIT-HeLaMONSTER transfection kit (Mirus,
MIR2900) and oligofectamine reagent (Invitrogen), respec-
tively, with the exception that the final concentration of
siRNA oligonucleotides was reduced to 10 nM for all exper-
iments. The siRNA oligonucleotides were purchased from
Dharmacon Inc. as SMART pool siGENOME duplexes
for human lipin 1 (NM_145693) and human lipin 2
(NM_014646). The siCONTROL nontargeting siRNA#1 was
used as the control for each siRNA knockdown experiment.
Unless otherwise stated, HeLaM cells were seeded 24 h prior to
transfection. The medium was changed 24 h after transfection,
and the cells were collected for analysis on day 4, 72 h post-
transfection. One single siGENOME duplex was chosen to rep-
resent each SMART pool, for lipin1 siGENOME duplex num-
ber 2 (D-017427-02) was used and for lipin2 siGENOME
duplex number 2 (D-013458-02). 3T3-L1 preadipocytes were
cultured and differentiated as previously described (17).
Flow Cytometry—HeLa M cells were collected by trypsin-
EDTA release. The cell suspension was centrifuged at800
g, and the cell pellet was washed once with chilled PBS contain-
ing 1 mg/ml BSA. The cells were then fixed with 70% ice-cold
ethanol and storedat20 °C for at least 4h.DNAwas labeledwith
propidium iodide (15 g/ml) in the presence of RNase (0.2
mg/ml), 1.1% trisodium citrate and 0.1%TritonX-100 for 30min.
The samples were then passed through a 70-m Nylon cell
strainer (BD Falcon) into a tube prior to flow cytometric determi-
nation of DNA content using a Becton Dickinson FACSCalibur
Flow cytometer. Propidium iodide levels were measured by
using the FLA-3 laser, and the cell cycle distributions were
determined through analysis on FlowJo software.
Retrovirus-mediated shRNA Knockdown—Two independent
short sequences specifically targeting lipin 1 and lipin 2 were
designed and cloned into the RNAi-Ready pSIREN-RetroQ
vector (Clontech) according to themanufacturer’s instructions.
Briefly, the primer pairs L101Bam/L101Eco, L103Bam/
L103Eco, L209Bam/L209Eco, and L210Bam/L210Eco were
annealed and ligated directly into the BamHI-EcoRI open
RNAi-ready pSIREN-RetroQ vector to yield the constructs
shRNA-L1A and shRNA-L1C for lipin 1 or shRNA-L2A or
shRNA-L2B for lipin 2, respectively. The pSIREN-Luc vector
containing shRNA targetting luciferase (Clontech) was used as
a control. Retroviral packaging BOSC-HEK293 cells were
transfected with these constructs to generate retroviruses to
infect 3T3-L1 cells. Virus collection, preparation, and infection
of cells were essentially as previously described in Ref. 17.
Cell Cycle Synchronization—For the double thymidine block,
HeLaM cells were arrested with 2.5 mM thymidine for 19 h and
released by washing two times inmedium and allowing them to
rest for 9 h, followed by a second 16 h arrest with 2.5 mM thy-
midine. The cells were then released from the block and
allowed to progress through the cell cycle. Mitotic cells were
collected by shake-off every 30 min, between 8 and 11 h after
release from the second cell cycle arrest. The nocodazole block
was achieved through an initial cell cycle arrest with 2.5 mM
thymidine for 19 h. The cells were then released from the block
by washing two times in medium and allowing them to recover
for 4 h. This was followed by a second 12-h arrest using 50
ng/ml of nocodazole. Mitotic cells were collected by shake-off.
Reverse Transcription-PCR—Total RNA was isolated using
the RNeasy kit (Qiagen) following themanufacturer’s protocol.
Reverse transcription and quantitative real time PCR was per-
formed as previously described (18). The primers used are
described in Table 1. All reverse transcription-PCRs were car-
ried out using 18 S rRNA as an internal control.
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Total Cell Lysates and Cell Fractionation—All of the steps
were performed at 4 °C. HeLa M cells were washed with PBS,
lysed, and centrifuged as described above. Supernatants were
diluted to yield 50 g of total protein/25 l of loading volume,
heated to 95 °C for 5 min, and resolved by SDS-PAGE followed
by Western blotting.
For cell fractionation, HeLa M cells were lysed as above in 50
mMTris-HCl (pH 7.4), 100M 4-(2-aminoethyl) benzenesulfonyl
fluoride, protease inhibitor complex tablets, phosphatase inhibitor
mixture I, 1g/mlDNase, 4mMMgCl2,with orwithout 1MNaCl,
1% Triton-X100, or both. Lysed cells were homogenized by pass-
ing through a 25GA needle 10 times before centrifuging at
100,000 g for 1h at 4 °C. Equivalent volumesof the supernatants
and the pellets weremixedwith sample buffer, heated to 95 °C for
5 min, and resolved by SDS-PAGE followed byWestern blotting.
3T3-L1-derivedadipocyteextractswereprepared in thesameway,
except that instead of syringing, the cells were lysed by sonication.
Cell Extract PAP Assays—HeLaM cell pellets were disrupted
by homogenization in 200l of 50mMTris-HCl (pH 7.5) buffer
containing 0.25 M sucrose, 10 mM 2-mercaptoethanol, protease
inhibitors (1 mM benzamidine, 0.5 mM phenylmethylsulfonyl
fluoride, 5 g/ml of aprotinin, leupeptin, and pepstatin). The
cell lysates were centrifuged at 1,000 g for 10min at 4 °C, and
the supernatant was used for the PAP assays as described in Ref.
9. Briefly, total PA phosphatase activity (Mg2-dependent and
Mg2-independent) wasmeasured for 20min at 30 °C in a total
volume of 100 l containing 50 mM Tris-HCl (pH 7.5), 1 mM
MgCl2, 10 mM 2-mercaptoethanol, 0.2 mM [32P]PA (10,000
cpm/nmol), 2 mM Triton X-100, and enzyme protein. The
Mg2-independent PAphosphatase activitywasmeasured sep-
arately under the same reaction condition except for the sub-
stitution of 1mMEDTA for 1mMMgCl2. TheMg2-dependent
PA phosphatase activity was calculated by subtracting the
Mg2-independent enzyme activity from total PA phosphatase
activity. The assay was performed in triplicate for each sample.
A unit of PA phosphatase activity was defined as the amount of
enzyme that catalyzed the formation of 1 nmol of product/min.
Indirect Immunofluorescence and Confocal Microscopy—
The cells were grown on sterile glass coverslips until they were
50% confluent and then washed three times with PBS before
being fixed in 3% (v/v) formaldehyde in PBS for 20 min. The cov-
erslipswere thenwashed three times in PBSwith the secondwash
containing 50mM glycine. The cells were permeabilized for 4min
with 0.01% Triton X-100 and then washed two times with PBS.
Each coverslip was blockedwith PBS containing 1mg/ml BSA for
20 min prior to incubation with primary antibodies for 30 min.
This was followed by three washes of 5 min in PBS containing 1
mg/ml BSA. The coverslips were then incubatedwith the second-
ary antibodies for 30 min in the dark. The coverslips were then
incubated with PBS containing 1 mg/ml BSA and 200 nM 4,6-
diamidino-2-phenylindole for 5 min, followed by two washes in
PBS containing 1mg/ml BSA. The coverslips weremounted onto
glass slides using ProLongGold antifade reagent (Invitrogen). The
cells were visualizedwith a 63 or 100PlanApochromat objec-
tive (numerical aperture, 1.4) on a Zeiss Axiovert 200M inverted
microscopewith an LSM510 confocal laser scanning attachment.
For live imaging, the cells were grown and imaged into CO2-inde-
pendent medium.
Antibodies—The following antibodies were used in this study:
anti-glyceraldehyde-3-phosphate dehydrogenase (Abcam;
ab9485), anti-HA[12CA5] (Santa Cruz; sc-805), anti-LaminB
(Santa cruz; sc-6217), anti-MPM2 (Upstate; 05-368), anti-
transferrin receptor [clone H678.4] (Invitrogen, Zymed Labo-
ratories Inc.; 13-6800), anti-cytochrome c (BD Pharmingen;
556432), anti-giantin (Abcam; ab24586), HRP-conjugated anti-
rabbit IgG light chain specific (Jackson Immunoresearch; 211-
032-171), HRP-conjugated anti-rabbit IgG (BD Pharmingen;
554021), HRP-conjugated anti-mouse (BD Pharmingen;
554002),HRP-conjugated anti-goat IgG (NovusBiologicals;NB
710-H), anti-goat IgG (H & L) (fluorescein isothiocyanate)
preadsorbed (Abcam; ab7121), anti-mouse IgG (H & L) highly
cross-adsorbed (Molecular probes; A11029), and anti-rabbit
IgG (H & L) highly cross-adsorbed (Molecular probes;
A11037). Crude rabbit sera from the final rabbit bleeds were
used for all lipin Western blots. Affinity-purified antibodies
were used for all lipin immunoprecipitations.
Immunoprecipitations and Lipin PAP1Assays—HeLaMcells
were lysed in 50 mM Hepes (pH 7.4), 1% Triton X-100, 150 mM
NaCl, 100M4-(2-aminoethyl)benzenesulfonyl fluoride,protease
inhibitor complex tablets (Roche Applied Science), phosphatase
inhibitor mixture I (Sigma), 1 g/ml DNase, 4 mMMgCl2 at 4 °C.
Lysed cells were homogenized by passing through a 25GA needle
10 times before centrifuging the homogenates at 16,000 g for 30
min. Supernatants were diluted to the same final concentration
TABLE 1
Primer
Primer pairs F18S/R18S were used for the quantification of 18 S rRNA. As an internal control, hL1F/hL1R and hL2F/hL2R were used for the quantification of lipin 1 and
lipin 2, respectively. The remaining primers were used for the construction of the shRNAs targeting lipin 1 and 2, as described under “Experimental Procedures.”
Primer name Primer sequence
F18S CGGCTACCACATCCAAGGAA
R18S GTCGGAATTACCGCGGCT
hL1F CCGACCAGCTGATGTGTATTCA
hL1R CTATCCTTTAATGGGTGACAACCA
hL2F CCCTGGACTTATAGACAATCCTAACC
hL2R GAGCTGGATGGCAGGTCACT
L1O1Bam GATCCGGGAACTCTGTAGACAGAATTTCAAGAGAATTCTGTCTACAGAGTTCCCTTTTTTCTCGAGG
L1O1Eco AATTCCTCGAGAAAAAAGGGAACTCTGTAGACAGAATTCTCTTGAAATTCTGTCTACAGAGTTCCCG
L1O3Bam GATCCGGTGGAGAGCACCTCCGACATTCAAGAGATGTCGGAGGTGCTCTCCACCTTTTTTCTCGAGG
L1O3Eco AATTCCTCGAGAAAAAAGGTGGAGAGCACCTCCGACATTCAAGAGATGTCGGAGGTGCTCTCCACCG
L2O9Bam GATCCGCCTCAGATTTCATCGCTATTTTCAAGAGAAATAGCGATGAAATCTGAGGCTTTTTTCTCGAGG
L2O9Eco AATTCCTCGAGAAAAAACCTCAGATTTCATCGCTATTTCTCTTGAAAATAGCGATGAAATCTGAGGCG
L2O10Bam GATCCGGGTAAAGACTGGACGCATCTTTCAAGAGAAGATGCGTCCAGTCTTTACCCTTTTTTCTCGAGG
L2O10Eco AATTCCTCGAGAAAAAAGGTAAAGACTGGACGCATCTTCTCTTGAAAGATGCGTCCAGTCTTTACCCG
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andmixedwith the antibody-proteinG-Sepharose complex.After
incubation at 4 °C for 2 h, the Sepharose beads were washed three
timeswith a 40-fold excess of lysis buffer followed by threewashes
with a 40-fold excess of PBS.
To dephosphorylate lipins, immune pellets were washed
three times with a 40-fold excess of wash buffer (50 mM Tris-
HCl, pH 7.4, 150 mMNaCl and 1 mM EDTA). One twentieth of
the immune pellets was removed forWestern blot analysis, and
the remainder was assayed for PAP1 activity, essentially as pre-
viously described (9). Briefly, immune pellets were centrifuged
at 3000 g for 1 min at 4 °C. The pellets were resuspended and
incubated in 100 l of the reaction buffer (50 mM Tris-HCl, pH
7.5, 1 mMMgCl2, 10mM 2-mercaptoethanol, 2 mMTriton X-100,
0.2mM [32P]PA, 10,000 cpm/nmol) for 20min at 30 °C, and PAP1
activity was measured by following the release of water-soluble
(32)Pi from chloroform-soluble [32P]PA. The assays were carried
out in triplicate. The PAP1 activity was normalized to reflect the
relative nominal protein levels andmeasured by scanning five dif-
ferent lowexposures ofWesternblot films and averaging the band
intensities using ImageJ software.
RESULTS
Mammalian Lipins Are Orthologues of the Yeast Pah1p—To
address whether the function of lipins is conserved throughout
evolution, we askedwhether themammalian lipin 1 and 2 could
function in the distantly related unicellular eukaryote Saccha-
romyces cerevisiae. The human lipin 1 (corresponding to the
short murine  form) and mouse lipin 2 open reading frames
were placed under the control of the PAH1 promoter and were
expressed in a yeast pah1 deletion mutant that lacks the
endogenous yeast lipin PAH1 gene. Lipin 2 fully rescued the
temperature-sensitive growth defect of the pah1 strain (Fig.
1B). The pah1 mutant cells contain enlarged and irregularly
shaped nuclei often consisting of two interconnected lobes
within a single cell and also accumulate nuclear/ERmembranes
into the cytoplasm. These structural defects are efficiently res-
cued by the expression of lipin 2 in pah1 cells, as judged by the
reappearance of round nuclei to the same extent as in pah1
cells expressing PAH1 (Fig. 1D). Lipin 1 could rescue the
growth defect of pah1 at 30 °C but not at 37 °C (Fig. 1B). Con-
sistent with this, expression of lipin 1 in pah1 cells resulted in
a partial restoration of nuclear morphology (Fig. 1D). To com-
pare the expression levels of the two lipins and Pah1p in the
pah1 cells, we expressed themasC-terminalGFP fusions. The
fusion proteins maintain their function because they are still
able to rescue the pah1 growth defect as efficiently as the
untagged proteins.4 The lipin 2-GFP is expressed in yeast at
similar levels as the Pah1p-GFP fusion (Fig. 1E). Although an
intact lipin1-GFP can be also detected, most of this fusion pro-
tein is broken down to a 70 kDa C-terminal product, pre-
dicted to contain the haloacid dehalogenase-like domain. No
other major degradation products were detected in the lipin
1-GFP sample.4 The breakdown of the lipin 1 fusion could
explain why it partially rescues the pah1 defects.
Next, we used a second assay to investigate whether lipins
can function in yeast. The combined knock-out of both the
nucleoporinNUP84 and the phosphatase subunit SPO7, which
dephosphorylates Pah1p, causes lethality (19). The synthetic
lethality of the nup84 spo7 strain can be rescued by the over-
expression of PAH1 (10). If lipins can provide the function of
Pah1p in yeast, they should also be able to rescue the synthetic
lethality of the nup84 spo7mutant. To test this hypothesis,
we used a nup84 spo7 double mutant complemented with a
centromeric plasmid with the URA3 marker, containing the
NUP84 gene (Fig. 1C). Because this strain cannot survive the
loss of the URA3-NUP84 plasmid, it will die when grown on
medium containing the drug 5-fluoroorotic acid that is toxic to
cells expressing theURA3 gene. If a functional or partially func-
tional PAH1 allele is introduced, then cells grown under non-
selective conditions can afford the loss of the URA3-NUP84
plasmid and can grow in the presence of 5-fluoroorotic acid.
Consistent with the complementation data described above,
lipin 2 expression can efficiently rescue the synthetic lethality of
the nup84 spo7 mutant, whereas lipin 1 displays a weaker
rescuing activity (Fig. 1C). Taken together, these data show that
the function of lipins is evolutionarily conserved from budding
yeast to mammals.
Distinct Intracellular Localizations for Lipin 1 and 2—In
contrast to the PA phosphatases of the lipid phosphate phos-4 N. Grimsey and S. Siniossoglou, unpublished data.
FIGURE 1. The function of lipin 1 and 2 is evolutionarily conserved from
yeast to mammals. A, primary structure of Pah1p, lipin 1, and lipin 2. The
conserved N-terminal domain and the C-terminal PAP domain are indicated.
B, lipin 2 rescues the temperature-sensitive growth defect of the pah1
mutant. pah1 cells were transformed with a 2 (high copy) vector contain-
ing the indicated genes, spotted on YEPD plates, and grown at 30 or 37 °C for
36 h. C, lipins can rescue the nup84 spo7 synthetic lethality. The nup84
spo7 double deletion strain carrying a URA3-containing vector expressing
NUP84 was transformed with the indicated plasmids. Transformants were
grown on plates containing 5-fluoroorotic acid for 3 days. No growth indi-
cates synthetic lethality.D, lipin 2 rescues the nuclear structure defects of the
pah1 cells. The pah1 mutant expressing an intranuclear reporter (PUS1-
GFP) was transformed with the same plasmids as in B and visualized by con-
focal microscopy. Arrows point to cells containing irregularly shaped/multi-
lobed nuclei. The percentage of cells containing a single round nucleus is
given. Two different transformants per strainwere analyzed and for each one
the number of cells counted was 200. Bars, 5 m. E, expression of lipin 1 and
lipin 2 in yeast. Protein extracts from pah1 cells expressing PAH1-GFP, lipin
1-GFP or lipin 2-GFP fusions and grown at 30 °C to early logarithmic phase
were analyzed by Western blot using anti-GFP antibodies.
Regulation of Lipin Activity
OCTOBER 24, 2008•VOLUME 283•NUMBER 43 JOURNAL OF BIOLOGICAL CHEMISTRY 29169
 by guest on September 12, 2013http://www.jbc.org/Downloaded from 
phatase (LPP) family and other enzymes involved in phospho-
lipid biosynthesis, lipins do not contain predicted transmem-
brane domains, suggesting that their interaction with
membrane surfaces is more tran-
sient. Antibodies against lipin 1 and
2 failed to visualize the endogenous
proteins in HeLa M cells using a
variety of different fixation proce-
dures.4 Therefore, to address their
localization, we transfected HeLaM
cells with lipin 1 and 2 as either HA
or GFP-tagged fusions. In fixed
cells, lipin 1-HA shows a predomi-
nantly cytosolic staining, whereas
lipin 2-HA shows a mixed soluble
and reticular staining and a nuclear
envelope-associated pool that is
reminiscent of ERproteins (Fig. 2A).
Lipin 2-HA did not show any signif-
icant co-localization with a mito-
chondrial or a Golgi marker (sup-
plemental Fig. S1). Consistent with
its reticular distribution, in live cells
a proportion of lipin 2-GFP fusion
shows co-localization with an endo-
plasmic reticulum marker, whereas
lipin 1-GFP shows again a diffuse
cytosolic distribution (Fig. 2B).
To investigate the subcellular dis-
tribution of the endogenous lipins,
we lysed HeLa M cells in the pres-
ence or absence of high salt, non-
ionic detergent or both and fol-
lowed their distribution in soluble
and insoluble fractions using anti-
bodies against lipin 1 and 2. The
majority of endogenous lipin 1 was
recovered in the soluble fraction,
even when cells were lysed in a
buffer lacking salt (Fig. 2C). Lipin 1 displays multiple electro-
phoretic forms (Fig. 2C, see also later) with the faster migrating
species partitioning mostly in the pellet and the slower migrat-
FIGURE 2. Subcellular localization of lipin 1 and 2. A, localization of lipin 1-HA and lipin 2-HA fusions in formaldehyde fixed HeLa M cells. Expression of
lipin-HA fusions was driven by the cytomegalovirus promoter. Bars, 5m. B, localization of lipin 1-GFP and lipin 2-GFP fusions in live HeLaM cells. Live HeLaM
cells transiently expressing a dsRed-ER reporter and lipin 1-GFP (upper panel) or lipin 2-GFP (lower panel) were visualized by confocalmicroscopy. Expression of
the tagged lipins was driven by the cytomegalovirus promoter. Bars, 5m. C, fractionation of endogenous lipin 1 and 2 in HeLaM cells. The cells were lysed in
either buffer alone or buffer containing 1 M NaCl, 1% Triton X-100, or both. The extracts were incubated for 20 min at 4 °C and then centrifuged at 100,000
g for 1 h. Equal volumes from the pellet (P) and supernatant (S) were loaded on an 8% SDS-PAGE and immunoblotted using the indicated antibodies.
FIGURE 3.Depletionof lipin 1 and2 inHeLaMcells.A, siRNAdown-regulates lipin 1 and 2mRNAandprotein
expression. The cells were transfected with either a nontargeting (Control), or lipin 1, lipin 2, or lipin 1 and 2
small interfering RNA duplexes. 72 h after transfection, mRNA (left panel) or protein (right panel) levels were
determined by real time PCR and immunoblotting, respectively, using the indicated antibodies. B, cell cycle
profiles of cells fromAwere determinedby flow cytometry as described under “Experimental Procedures.” The
significance of the differencebetween control and lipin 1 siRNA-treated cells found in theG1 phase is indicated
by p  0.00005. The data are averages from eight independent experiments. C, lipin 1 is the major PAP1
enzyme in HeLa M cells. Control and lipin siRNA-treated cells were lysed 72 h after the knock-down, and PAP
assays were performed as described under “Experimental Procedures.” The results shown were determined
from triplicate enzyme assays S.D. and were reproduced in two independent experiments.
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ing bands found in the soluble fraction. Interestingly, and
unlike lipin 1, which is solubilized in the presence of detergent,
the insoluble pool of lipin 2 is resistant to extraction even in the
presence of 1 MNaCl or 1%Triton X-100. The insoluble pool of
lipin 2 can be solubilized only with a combination of both high
salt and nonionic detergent (Fig. 2C). Thus, although both lip-
ins dephosphorylate PA in phospholipid bilayers, they exhibit
distinct affinities for membranes in HeLa M cells.
Reciprocal Regulation of Lipin 1 and 2 Controls Cellular
PAP1 Activity in HeLa M Cells—To investigate their cellular
functions, we depleted lipin 1 and lipin 2 in HeLaM cells using
siRNA. To this end we used two different siRNA oligonucleo-
tides for each lipin that could, independently, deplete efficiently
the respective proteins 72 h after their transfection (Fig. 3A and
data not shown). Notably, depletion of either lipin resulted in
an increase of both the mRNA and protein levels of the other
lipin (Fig. 3A), suggesting that the knock-down cells activate a
compensatorymechanism.Cell cycle analysis shows that deple-
tion of lipin 1 for 72 h causes a 6.3% increase in the relative
number of cells in G1 phase, whereas depletion of lipin 2 has no
effect (Fig. 3B).
Because both lipin 1 and 2 are expressed in HeLaM cells, we
set out to compare their relative contribution in the regulation
of the cellularMg2-dependent PA phosphatase activity. To do
this, we silenced lipin 1, lipin 2, or both in HeLa M cells, pre-
pared extracts 72 h after transfection of the respective siRNAs
andmeasured the PAP1 and PAP2 activities. Importantly, lipin
1-depleted extracts show an 86% reduction in the total cellular
PAP1 activity, indicating that lipin 1 is the major PAP1 enzyme
in these cells (Fig. 3C). Surprisingly, knock-down of lipin 2 has
the opposite effect and results in a dramatic increase in the
cellular PAP1 levels (Fig. 3C). This could be explained by the
fact that lipin 1 levels increase significantly in the lipin 2-de-
pleted cells, leading to an increase in the total PAP1 activity.
The combined lipin 1 and 2 knock-down led to a further small
but significant decrease of the PAP1 activity (Fig. 3C). On the
other hand, the Mg2-independent PA phosphatase (PAP2)
activity did not change in any of the lipin-depleted cells (Fig.
3C). Taken together, the complementary up-regulation of each
lipin in the respective knock-down and its effect on cellular
PAP1 activity strongly suggest that lipin 1 is the more active
enzyme, whereas the activity of lipin 2 is more tightly regulated
in HeLa M cells.
Reciprocal Regulation of Lipin 1 and 2 in Differentiating
Adipocytes—The reciprocal regulation of the levels of the two
lipins in HeLaM cells prompted us to test how their expression
is coordinated during adipogenesis where PAP1 activity is
required for the biosynthesis of the storage lipid triacylglycerol.
To address this question, 3T3-L1 preadipocytes were induced
to differentiate and protein extracts were prepared at various
time points afterward. As seen in Fig. 4A, lipin 2 is expressed in
preadipocytes and also during the early stages of adipogenesis
before its levels decrease almost to undetectable levels in
mature adipocytes. Lipin 1 shows a reciprocal pattern with no
detectable expression in preadipocytes and a gradual increase
after 48 h of differentiation, which coincides with a decrease
in lipin 2 levels (Fig. 4A). Lipin 1 is expressed first as a low
and subsequently as a higher molecular weight protein band
on SDS-PAGE that persists in mature adipocytes, probably
corresponding to the two isoforms of lipin 1 generated by
alternative splicing (12). Interestingly, lipin 2 is also expressed
as a high and low molecular weight protein band on SDS-
PAGE, but in this case the higher band is due to phosphoryla-
tion as it resolves to the lower form following phosphatase
treatment of the immunoprecipitated protein (Fig. 4B).
The fact that lipin 1 is the major PAP1 enzyme in HeLa M
cells suggests that the change in the ratio between the protein
levels of lipin 1 and 2 during adipogenesis could contribute to
the maintenance of high biosynthetic PAP1 activity required
for bulk triglyceride production. To test this hypothesis, we
quantified the PAP1 activity during the differentiation of 3T3
preadipocytes. Indeed, cellular PAP1 levels increase steadily
24 h after induction of differentiation and peak at the 192-h
time point, overlapping significantly with the induction pattern
of lipin 1 (Fig. 5).
To examine whether expression of the different lipins is co-
regulated during adipocyte differentiation, we silenced lipin 1
or lipin 2 by infecting 3T3-L1 preadipocytes with retroviruses
FIGURE 4. Reciprocal pattern of lipin 1 and 2 protein expression during
adipogenesis. A, 3T3-L1 preadipocytes were induced to differentiate for 12
days. At the indicated time points, the cell lysates were prepared, protein
concentrations were measured by Bradford assay, and equal protein
amounts/time point were analyzed by SDS-PAGE followed by immunoblot-
ting using lipin 1 and 2 antibodies. Adipocyte differentiation was monitored
by following P2 expression. B, lipin 2 is phosphorylated in 3T3-L1 cells.
Endogenous lipin 2 was immunoprecipitated (IP) from extracts of 3T3-L1
preadipocytes. Immune pellets were incubated with or without -phospha-
tase (PPase) and analyzed by SDS-PAGE followed by immunoblotting using
lipin 2 antibodies. FIGURE 5. PAP1 activity increases during adipogenesis. 3T3-L1 preadipo-
cytes were induced to differentiate for 12 days. At the indicated time points,
the cell lysates were prepared, and the PAP1 and PAP2 activities were meas-
ured as described under “Experimental Procedures.” The values for each time
point were determined from triplicate enzyme assays  S.D. A unit of PA
phosphatase activitywasdefinedas theamountof enzyme that catalyzed the
formation of 1 nmol of product/min. Specific activitywas defined as units/mg
protein.
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carrying shRNAs specifically targeting their mRNA sequences.
For each lipin, two cell lines were constructed, each expressing
a different shRNA (see “Experimental Procedures”), and the
results described below were reproduced with both. Infection
of the cells with shRNA targeting either lipin 1 or lipin 2
resulted in an efficient decrease in the levels of the respective
protein (Fig. 6). Notably, in lipin 1 knock-down cells, lipin 2
protein levels significantly increased at all time points exam-
ined and persisted for longer during differentiation (Fig. 6).
Despite the increased lipin 2 levels, depletion of lipin 1 inhibited
the differentiation of preadipocytes to mature adipocytes as
judged by the failure to induce aP2 expression (Fig. 6) or to
accumulate intracellular lipid (triacylglycerol/steryl esters), fol-
lowed byNile Red staining.4 In contrast, depletion of lipin 2 did
not inhibit adipogenesis. Indeed, knock-down of lipin 2 led to a
more rapid and robust induction of aP2, suggesting that adipo-
genesis may be accelerated in these cells (Fig. 6). Together,
these data are consistent with the reciprocal regulation of the
two lipins observed in HeLa M cells and also indicate that they
perform distinct functions in differentiating adipocytes.
Mitotic Phosphorylation of Lipin 1 and 2 Inhibits Their PA
Phosphatase Activity—We next asked whether the function of
the two lipins could also be regu-
lated by post-translational modifi-
cations. The fact that the yeast lipin
Pah1p is phosphorylated during
mitosis (10) and that the mamma-
lian lipins can functionally replace
the yeast enzyme (Fig. 1) prompted
us to test whether lipin 1 and 2 are
also mitotically phosphorylated. To
address this possibility, endogenous
lipin 1 and 2 were immunoprecipi-
tated from asynchronous or mitotic
HeLaM cells, generated by nocoda-
zole arrest, and analyzed by West-
ern blotting. As seen in Fig. 7A, both
lipins undergo mobility shifts that
reduce their electrophoretic mobil-
ity in the nocodazole-arrested sam-
ples. This mobility shift is due to
phosphorylation because it can be
reversed in a concentration-
dependent manner after incubation
of the immunoprecipitated proteins
with -phosphatase (Fig. 7B and
data not shown). Importantly, the
hyperphosphorylated lipin 1 and 2
forms are recognized by MPM2, a
monoclonal antibody that is spe-
cific for phospho-Ser/Thr-Pro
sites, the minimal Cdk1 phospho-
rylation motif (20) (Fig. 7A).
To independently confirm that
lipins are mitotically phosphoryla-
ted, we immunoprecipitated them
from mitotic cells synchronized
with a different procedure. HeLa M
FIGURE 6. shRNA-mediated silencing of lipin 1 and 2 in differentiating
adipocytes. 3T3-L1 preadipocytes stably transfected with retroviral vectors
expressing shRNA targeting lipin 1 (Lipin 1), lipin 2 (Lipin 2) or a control
sequence (Control), were induced to differentiate for 8 days. At the indicated
time points, the cell lysates were prepared, the protein concentrations were
measured by Bradford assay, and equal protein amounts/time point were
analyzed by SDS-PAGE followed by immunoblotting using the indicated
antibodies.
FIGURE 7.Mitotic phosphorylation of lipin 1 and 2 regulates their PAP1 activity. A, lipins are phosphoryl-
ated on Cdk1 motifs during mitosis. Left panel, Endogenous lipin 1 and lipin 2 were immunoprecipitated (IP)
from extracts of asynchronous (Asy) or mitotic HeLa M cells synchronized either by nocodazole arrest (Noc) or
double thymidine arrest at the G1/S boundary followed by release and collection during mitosis (8–10 h
post-release) (D. Thy). Immune pellets were analyzed by Western blotting using anti-lipin 1, anti-lipin 2, and
anti-phospho-Ser/Thr-Pro (MPM2) antibodies. Right panel, flow cytometry of the cells used for the lipin immu-
noprecipitations. B, mitotic phosphorylation of lipins inhibits their PAP1 activity.Upper panel, immunoprecipi-
tated lipin 1 and 2 from asynchronous or nocodazole-treated HeLa M cells with or without incubation with
-phosphatase (PPase) were analyzed by Western blotting as indicated. Mock immunoprecipitations were
performed using the preimmune lipin 1 and 2 sera. Lower panel, immune pellets from the above immunopre-
cipitations were assayed for PAP1 activity as described under “Experimental Procedures.” The results shown
were determined from triplicate enzymeassays S.D. Thedata for the asynchronous andnocodazole samples
are the averages from two independent experiments. C, total PAP1 activity decreases during mitosis. Lysates
from asynchronous ormitotic cells were assayed for PAP1 and PAP2 activity as described under “Experimental
Procedures.” The results shown were determined from triplicate enzyme assays S.D. D, mitotic phosphoryl-
ation of lipins regulates their membrane recruitment. Lysates from asynchronous or mitotic cells were centri-
fuged at 100,000 g. Equal volumes from the pellet (P) and supernatant (S) were immunoblotted using the
indicated antibodies.
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cells were synchronized at the G1/S boundary by double thymi-
dine block and released to allow progression intoM phase, and
then lipins were immunoprecipitated. Consistent with the
results obtained from the nocodazole treated cells, mitotic
HeLa M cells synchronized by the double thymidine block also
result in MPM2-specific phosphorylation of lipin 1 and 2 (Fig.
7A). Taken together, these data demonstrate that lipin 1 and 2
are mitotically phosphorylated on Cdk1 consensus sites.
Next we examined the effect of the mitotic phosphorylation
on the function of lipins. We first asked whether phosphoryla-
tion could regulate the PA phosphatase activity of lipin 1 and 2.
To address this, endogenous lipin 1 and 2were immunoprecipi-
tated from asynchronous or nocodazole-arrested HeLa M cells
with orwithout -phosphatase treatment, and the immune pel-
lets were then assayed for Mg2-dependent PA phosphatase
activity. As seen in Fig. 7B, mitotic phosphorylation of both
lipin 1 and 2 decreases their PA phosphatase activity, whereas
dephosphorylation stimulates it. Consistentwith a role of phos-
phorylation in inhibiting the activities of the lipins, the total
Mg2-dependent PAP activity (PAP1) in the extracts of
nocodazole-arrested HeLa M cells decreased when compared
with the activity of asynchronous cells (Fig. 7C). On the other
hand, the total Mg2-independent activity (PAP2), which is
mediated by the LPP family of phosphatases, responded in the
opposite way and showed increased levels in the nocodazole-
derived extracts (Fig. 7C).
Phosphorylation also regulates membrane recruitment of
lipin 1 and 2 in HeLa M cells. As seen in Figs. 2C and 7D, the
slowmigrating forms of lipin 1 are significantly enriched in the
soluble fractions of both the asynchronous and mitotic cell
lysates. Similarly, in the nocodazole-treated cells, only the
phosphorylated lipin 2 becomes soluble. Taken together, these
data show that mitotic phosphorylation of lipin 1 and 2 is a
major determinant of their function in HeLa M cells, by con-
trolling both their PAP1 activity and membrane recruitment.
DISCUSSION
In contrast to yeasts, nematodes, and flies that express only
one lipin, mammals express three lipins that display overlap-
ping expression in many different tissues. This observation
raises two interesting questions: first, whether there are func-
tional differences between the lipins, and second, how cells
coordinate the activities of different lipins during growth and
development.
Our results show that there are two major differences
between lipin 1 and 2 inHeLaM cells. First, the two lipins show
distinct intracellular localization, with lipin 1 exhibiting amore
soluble distribution and lipin 2 exhibiting a detergent- and salt-
insoluble pool. In this context it is interesting to notice that
although the murine lipin 1 is primarily intranuclear in
HEK293 and 3T3-L1-derived adipocytes (11, 12), we found that
its apparent human homologue displays a cytosolic localization
in HeLa M cells. The basis for this difference is not clear. Lipin
2 displays also a distinct ER-associated pool. Because the vari-
ous lipin paralogues exhibit overlapping expression in many
different tissues (14), their distinct localization raises the inter-
esting possibility of the compartmentalization of the PAP1
reaction and thus control of PA,DAG, and phospholipid home-
ostasis, on different organelles. Because lipins have very similar
domain organization, their targeting to different intracellular
compartments might be mediated by interaction with different
binding partners. Second, the levels of lipin 1, but not lipin 2,
correlate with the cellular PAP1 activity in HeLaM cells. Thus,
siRNA-mediated depletion of lipin 1 leads to a dramatic
decrease of PAP1 activity. This is consistent with the absence of
PAP1 activity in tissues from the fld mouse that expresses an
inactivemutant lipin 1 allele (13, 14). On the other hand, deple-
tion of lipin 2 has the opposite effect and leads to an increase of
both lipin 1 expression and PAP1 activity levels. Thus, lipin 1 is
themajor PAP1 enzyme in HeLaM cells. Higher lipin 2 protein
levels in lipin 1 siRNA and shRNA experiments in HeLaM and
3T3-L1 cells, respectively, do not compensate the relevant
knock-downphenotypes, indicating that the two lipins perform
non-redundant functions in lipid biosynthesis.
The different functions of the two lipins could explain the
temporal regulation of their expression during adipogenesis.
Cellularmodels of adipogenesis suggest that preadipocytes first
become committed to differentiation, followed by a limited
proliferation and a final maturation process when they acquire
their specialized adipogenic properties, including lipid accu-
mulation (21). Lipin 1 is not expressed in the preadipocytes,
which suggests that lipin 2 and possibly lipin 3 are able to pro-
vide the necessary PAP1 activity prior to differentiation. On the
other hand, expression of a highly active PAP1 enzyme is
needed to support bulk triglyceride production at the final
stages of differentiation. Interestingly, depletion of lipin 2 cor-
relates with an earlier appearance of both the adipogenic
marker aP2 (Fig. 6) and lipid accumulation.4 Thus, the levels of
lipin 2 are able to indirectly influence adipogenesis. This mir-
rors the situation in HeLa M cells, where lipin 2 knock-down
increases cellular PAP1 activity and underscores the signifi-
cance of the temporal regulation of lipin 1 expression.
Another important finding of this work is that phosphoryla-
tion of lipins inhibits their PAP1 activity during mitosis. What
could be the function of this inhibition? Phospholipids accumu-
late in the S phase, whereas their synthesis is inhibited during
the G2/M phase, when cellular metabolism reaches the lowest
rate in the cell cycle (22). The decrease of the PAP1 activity
caused by the mitotic phosphorylation of lipin 1 and 2 could
contribute to the inhibition of phospholipid accumulation
prior to cell division. Interestingly, CCT1, the enzyme cata-
lyzing the rate-limiting step in the biosynthesis of phosphati-
dylcholine, is also inactivated by hyperphosphorylation late in
the cell cycle (22). These data are consistentwith amodelwhere
biosynthetic production of phospholipids is inhibited at multi-
ple steps during cell division. Phospholipid biosynthesis is also
developmentally regulated, and recent studies found that tran-
scription of lipin 1 is induced in cells that undergo ER prolifer-
ation (23, 24). It will be interesting to test whether dephospho-
rylation-dependent activation of lipins accompanies some of
these transcriptional changes.
Contrary to the results presented here, a recent study found
that dephosphorylation of adipocyte lipin 1 does not have any
effect on its PAP1 activity (13). It is possible that the kinases
responsible for the phosphorylation of lipin 1 in adipocytes and
in mitotic HeLa M cells are not the same. Accordingly, phos-
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phorylation of lipin 1 at different sites could have different
functional consequences in either cell line. Alternatively, these
differences could be due to the different responses of the two
lipin 1 isoforms to phosphorylation. Adipocytes, which were
used by Harris et al. (13) as a source of lipin 1, express mostly
the longer  form (12), whereas HeLaM cells used to immuno-
precipitate lipin 1 in our assays express two forms that differ
slightly in their electrophoreticmobilities (Fig. 7B), presumably
representing the  and  forms. It is possible that dephospho-
rylation of only one isoform () is responsible for the increase in
PAP1 activity.
Proteins that regulate the phosphorylation state of lipins are
expected to influence PAP1 activity and consequently lipid and
membrane biogenesis. A recent study reported that Dullard,
the mammalian orthologue of the protein phosphatase Nem1p
that regulates Pah1p activity and nuclear membrane growth in
yeast (10), localizes to the inner side of the nuclear envelope and
dephosphorylates lipin 1 in BHK cells (25). Because Pah1p reg-
ulates nuclear membrane biogenesis in yeast, this finding raises
the intriguing possibility that lipins could perform a similar
function in mammalian cells. Future experiments will address
these possibilities.
In summary, we provide the first evidence that the two
related PA phosphatases lipin 1 and 2 display differences in
their localization, expression pattern, and activity. Such a dif-
ferential regulation of the PAP1 activity could explain why
higher eukaryotes evolved multiple lipin paralogues. This also
suggests that although lipin 1 is the major PAP1 enzyme in
HeLaM cells andmurine adipocytes, lipin 2 and 3 have as of yet
undetermined important roles. The future determination of the
specific functions of each lipin is important to understand how
these enzymes control the biosynthetic production of lipids,
lipid signaling, cell differentiation, and membrane growth.
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